Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time

Vaccine

Volumn 14, Issue 12, 1996, Pages 1108-1110

  Kunzel W ^a   Glathe, H ^a   Engelmann, H ^a   Van Hoecke, Ch ^b  

^a Sächsisches Serumwerk GmbH   (Germany)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Immune response; Influenza vaccination; Revaccination

Indexed keywords

INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; KINETICS; NORMAL HUMAN; PRIORITY JOURNAL; REVACCINATION;

EID: 0030581408     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00061-8     Document Type: Article

References (16)

1. 1 Ada, G.L. and Jones, P.D. The immune response to influenza infection. Curr. Topics Microbiol. Immun. 1986, 128, 1-54
2. 2 Davies, J.R. and Grilli, E.A. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol. Infect. 1989, 102, 325-333
3. 3 Hobson, D., Curry, R.L., Beare, A.S. and Ward-Gardner, A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. (Lond.). 1972, 70, 767-777
4. 4 Keitel, W.A., Cate, T.R. and Couch, R.B. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am. J. Epidemiol. 1988, 127, 353-364
5. 5 World Health Organization Recommended composition of influenza virus vaccines. Wkly epidemiol. Rec. 1993, 68, 57-60
6. 6 US Dept of Health and Human Services: influenza virus reagents for the haemagglutination inhibition test. CDC, Technical Services Branch, 1991, Atlanta, USA
7. 7 Monto, A.S. and Maassab, H.F. Ether treatment of influenza type B for the haemagglutination test. J. Clin. Microbiol. 1981, 13, 54-57
8. 8 World Health Organization Influenza in the World. 1. October 1990-30. September 1991. Wkly epidemiol. Rec. 1991, 66, 369-376
9. 9 Chernesky, M., O'Neill, D., Pickard, I. et al. lmmunogenicity and adverse reactions of influenza vaccination in elderly patients given acetaminophen or placebo. Clin. Diagn. Virol. 1993, 1, 129-136
10. 10 Cox, R.J., Brokstad, K.A., Zuckerman, M.A., Wood, J.M., Haaheim, L.R. and Oxford, J.S. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 1994, 12, 993-999
11. 11 Pyhälä, R., Alanko, S., Forsten, T et al. Early kinetics of antibody response to inactivated influenza vaccine. Clin. Diagn. Virol. 1994, 1, 271-278
12. 12 Powers, R.G., Hayden, F.G., Samuelson, J. and Gwaltney, J.M. Immune response of adults to sequential influenza vaccination. J. Med. Virol. 1984, 14, 169-175
13. 13 Künzel, W., Engelmann, H. and D'Hondt, E. Immune response to influenza vaccination. Lancet 1994, 343, 173
14. 14 Zuckerman, M.A., Wood, J., Chakroverty, P., Taylor, I., Heath, A.B. and Oxford, J.S. Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response. J. Med. Virol. 1991, 33, 133-137
15. 15 Zuckerman, M., Cox, R., Taylor, I., Wood, J., Haakeim, L. and Oxford, J. Rapid immune response to influenza vaccination. Lancet 1993, 342, 113
16. 16 Commission of the European Communities: Harmonization of requirements for influenza vaccine. III/3188/91-En